XERS
Is Xeris Biopharma Holdings, Inc. (XERS) a good Buffett stock?
Xeris Biopharma Holdings, Inc. (XERS) is analysed against the documented Warren Buffett framework on this page. The Buffett-Fit score grades the stock A+ to D across five pillars (moat, earnings durability, management quality, financial health, valuation), each on a 0-100 sub-scale. The full reasoning behind every pillar is below. Educational only, not investment advice.
Five pillars at a glance. Xeris Biopharma Holdings, Inc.'s Buffett-Fit score weighs ROIC sustainability (currently 0.1%), gross-margin durability (0.8%), net-debt-to-EBITDA (-1.66x), free-cash-flow conversion (50.42x net income), and the owner-earnings yield (2.5%). Each pillar is scored 0-100 against sector-relative benchmarks.
Where XERS passes the test. A Buffett-style holding needs durable returns, conservative debt, owner-friendly management, and a price below intrinsic value. The full pillar breakdown on /buffett/xers/ shows where Xeris Biopharma Holdings, Inc. clears each bar - and where it doesn't.
What the score does NOT say. A high Buffett-Fit grade is a pattern-match against documented criteria, not a forecast. A stock graded A+ today can underperform if its underlying business deteriorates faster than the score updates. A D-graded stock can outperform if it's a value trap that recovers. The score weighs current fundamentals against a documented framework - that's all it claims to do.
How invest-like measures this
The Buffett-Fit framework on invest-like grades any public stock A+ to D on a 0-100 scale across five weighted pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety).
Each pillar is scored on the same 0-100 sub-scale using the rubric Warren Buffett has documented across 50+ years of Berkshire Hathaway shareholder letters. The overall grade is the weighted average. Educational only - pattern-match against documented public criteria, not personalised investment advice.
More questions about XERS
Dive deeper into XERS
Related on invest-like
Educational framework analysis only. Not investment advice, not a recommendation, not personalized to your situation. Always do your own research.